6 results for author:"Hassiepen U." in Literature citations
Results Customize
› Repeat search in UniProtKB (3)
| Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes. Sutton J.M., Clark D.E., Dunsdon S.J., Fenton G., Fillmore A., Harris N.V., Higgs C., Hurley C.A., Krintel S.L., MacKenzie R.E. et al. Bioorg. Med. Chem. Lett. 22:1464-1468(2012) · Mapped (1) |
| A macrocyclic HCV NS3/4A protease inhibitor interacts with protease and helicase residues in the complex with its full-length target. Schiering N., D'Arcy A., Villard F., Simic O., Kamke M., Monnet G., Hassiepen U., Svergun D.I., Pulfer R., Eder J. et al. Proc. Natl. Acad. Sci. U.S.A. 108:21052-21056(2011) · Mapped (1) |
| The crystal structure of caspase-6, a selective effector of axonal degeneration. Baumgartner R., Meder G., Briand C., Decock A., D'arcy A., Hassiepen U., Morse R., Renatus M. Biochem. J. 423:429-439(2009) · Mapped (1) |
| Characterization of the catalytic activity of the membrane-anchored metalloproteinase ADAM15 in cell-based assays. Maretzky T., Yang G., Ouerfelli O., Overall C.M., Worpenberg S., Hassiepen U., Eder J., Blobel C.P. |
| Structural basis of ubiquitin recognition by the deubiquitinating protease USP2. Renatus M., Parrado S.G., D'Arcy A., Eidhoff U., Gerhartz B., Hassiepen U., Pierrat B., Riedl R., Vinzenz D., Worpenberg S. et al. |
| Crystal structure of human BACE2 in complex with a hydroxyethylamine transition-state inhibitor. Ostermann N., Eder J., Eidhoff U., Zink F., Hassiepen U., Worpenberg S., Maibaum J., Simic O., Hommel U., Gerhartz B. J. Mol. Biol. 355:249-261(2006) · UniProtKB (1) |